Plasmapheresis rescue therapy in progressive systemic ANCA-associated vasculitis: Single-center results of stepwise escalation of immunosuppression

Journal of Clinical Apheresis

Volumn 29, Issue 5, 2014, Pages 266-272

  De Joode, Anoek A E ^a   Sanders, Jan S F ^a   Smid, W Martin ^b   Stegeman, Coen A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b CENTRAL LABORATORY   (Netherlands)

Author keywords

Apheresis; Auto immunity; Granulomatosis with polyangiitis; Microscopic polyangiitis

Indexed keywords

C REACTIVE PROTEIN; CREATININE; CYCLOPHOSPHAMIDE; FRESH FROZEN PLASMA; METHYLPREDNISOLONE; MYELOBLASTIN; PREDNISOLONE; STEROID;

ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; BACTERIAL INFECTION; BIRMINGHAM VASCULITIS ACTIVITY SCORE; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DEATH; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE COURSE; DRUG MEGADOSE; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY BIOPSY; KIDNEY FUNCTION; LEUKOPENIA; LONG TERM CARE; LUNG DISEASE; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NECROSIS; OUTCOME ASSESSMENT; PLASMAPHERESIS; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; THROMBOSIS; TREATMENT RESPONSE; VASCULITIS; VIRUS INFECTION;

EID: 84907931926     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.21318     Document Type: Article

References (20)

1. Jayne DRW, Gaskin G, Rasmussen N, Abramowicz D, Ferrario F, Luillevin L, Mirapeix E, Savage COS, Sinico RA, Stegeman CA, Westman KW, Van der Woude FJ, de Lind van Wijngaarden RAF, Pusey CD; on behalf of the European Vasculitis Study Group Randomized trial of plasma exchange or highdosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 2007;18:2180-2188.
2. Tesar V, Jelinkova E, Masek Z, Jirsa M, Zabka J, Bartunkova J, Stejskalova A, Janatkova I, Zima T. Influence of plasma exchange on serum levels of cytokines and adhesion molecules in ANCA-positive renal vasculitis. Blood Purif 1998;16:72-80.
3. Klemmer PJ, Chalermskulrat W, Reif MS, Hogan SL, Henke DC, Falk RJ. Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small vessel vasculitis. Am J Kidney Dis 2003;42:1149-1153.
4. Lionaki S, Falk RJ. Removing antibody and preserving glomeruli in ANCA small-vessel vasculitis. J Am Soc Nephrol 2007;18:1987-1994.
5. Nguyen T, Martin MK, Indrikovs AJ. Plasmapheresis for diffuse alveolar hemorrhage in a patient with wegeners granulomatosis: case report and review of the literature. J Clin Apher 2005;20:230-234.
6. Mahr A, Chaigne-Delalande S, de Menthon M. Therapeutic plasma exchange in systemic vasculitis: an update on indications and results. Curr Opin Rheumatol 2012;24:261-266.
7. Szpirt WM, Heaf JG, Petersen J. Plasma exchange for induction and cyclosporine A for maintenance of remission in Wegener's granulomatosis - a clinical randomized controlled trial. Nephrol Dial Transplant 2011;26:206-213.
8. Walsh M, Catapano F, Szpirt W, Thorlund K, Bruchfeld A, Guillevin L, Haubitz M, Merkel PA, Peh CA, Pusey C, Jayne D. Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis. Am J Kidney Dis 2011;57:566-574.
9. Hagen EC, Daha MR, Hermans J, Andrassy K, Csernok E, Gaskin G, Lesavre P, Ludemann J, Rasmussen N, Sinico RA, Wijk A, van der Woude FJ. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. Kidney Int 1998;53:743-753.
10. Falk RJF, Jennette JC. ANCA small-vessel vasculitis. J Am Soc Nephrol 1997;8:314-322.
11. Jayne D. Clinical management and treatment of vasculitis. Semin Immunopathol 2001;23:267-286.
12. Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W, Mahr A, Segelmark M, Cohen tervaert JW, Scott D. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 2007;66:222-227.
13. Pusey CD, Rees AJ, Evans DJ, Peters DK, Lockwood CM. Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int 1991;40:757-763.
14. Gregersen J, Kristensen T, Krag S, Birn H, Ivarsen P. Early plasma-exchange improves outcome in PR3-ANCA positive renal vasculitis. Clin Exp Rheumatol 2012;30(1 Suppl 70):S39-S47.
15. Stegeman CA. Anti-neutrophil cytoplasmic antibody (ANCA) levels directed against proteinase-3 and myeloperoxidase are helpful in predicting disease relapse in ANCA-associated smallvessel vasculitis. Nephrol Dial Transplant 2002;17:2077-2080.
16. Walsh M, Casian A, Flossmann O, Westman K, Hoglund P, Pusey C, and DRW Jayne of behalf of the European Vasculitis Study Group (EUVAS). Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment in unclear. Kidney Int 2013;84:397-402.
17. Pepper RJ, Chanouzas D, Tarzi R, Little MA, Casian M, Walsh M, Pusey CD, Harper L, Salama AD; European Vasculitis Study (EUVAS) investigators, Intravenous cyclophosphamide and plasmapheresis in dialysis-dependent ANCA-associated vasculitis. Clin J Am Soc Nephrol 2013;8:219-224.
18. Aydin Z, Gursu M, Karadag S, Uzun S, Tatli E, Sumnu A, Ozturk S, Kazancioglu R. Role of plasmapheresis performed in hemodialysis units for the treatment of anti-neutrophilic cytoplasmic antibody-associated systemic vasculitides. Ther Apher Dial 2011;15:493-498.
19. Smith RM, Jones RB, Guerry MJ, Laurino S, Catapano F, Chaudhry A, Smith KG, Jayne DR. Rituximab for remission maintenance in relapsing ANCA-associated vasculitis. Arthritis Rheum 2012;64:3760-3769.
20. Rutgers A, Kallenberg CG. Refractory disease in antineutrophil cytoplasmic antibodies associated vasculitis. Curr Opin Rheumatol 2012;24:245-251.